MoneyWorks4Me

Aurobindo Pharma informs about analyst meet

06 Jul 2023 Evaluate

Aurobindo Pharma has informed that the officials of the Company will be participating in the investor / analyst meeting with ‘East Bridge Capital’ on July 6, 2023 at 11.00 am in Hyderabad. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1752.50
Dr. Reddys Labs. 1180.00
Cipla 1305.00
Lupin 1942.00
Zydus Lifesciences 1115.20
View more..